Agenus Inc.
AGENUnited States
32 filed reports · 466 financial concepts · 12 earnings calls
Latest figures
Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.
Latest fiscal year
Filed reports
32 reports · Dec 2019 to Sep 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 4 operating metrics, 4 earnings-release figures, 39 commentary passages.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 21 | 4,026 | Mar 2020 to Sep 2026 |
| Annual · 10-KSEC EDGAR | 7 | 3,836 | Dec 2019 to Dec 2025 |
| Current · 8-KSEC EDGAR | 4 | 7 | Jun 2025 to Sep 2026 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q3 | 8-K | 2026-09-30 | 2026-11-05 | 4 | Open |
| FY2026 Q3 | 10-Q | 2026-09-30 | 2026-11-05 | 455 | Open |
| FY2026 Q2 | 10-Q | 2026-06-30 | 2026-08-07 | 234 | Open |
| FY2026 Q2 | 8-K | 2026-06-30 | 2026-08-06 | 1 | Open |
| FY2026 Q1 | 10-Q | 2026-03-31 | 2026-05-11 | 237 | Open |
| FY2025 | 10-K | 2025-12-31 | 2026-03-16 | 1,045 | Open |
| FY2025 Q4 | 8-K | 2025-12-31 | 2026-03-16 | 1 | Open |
| FY2025 Q3 | 10-Q | 2025-09-30 | 2025-11-10 | 204 | Open |
| FY2025 Q2 | 8-K | 2025-06-30 | 2025-08-11 | 1 | Open |
| FY2025 Q2 | 10-Q | 2025-06-30 | 2025-08-11 | 157 | Open |
| FY2025 Q1 | 10-Q | 2025-03-31 | 2025-05-12 | 153 | Open |
| FY2024 | 10-K | 2024-12-31 | 2025-03-17 | 514 | Open |
Financial data
466 concepts · 7,869 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial455 concepts · 7,203 facts · Dec 2017 to Sep 2026
- Net income loss available to common stockholders basic44 · Dec 2017 to Sep 2026
- Revenue44 · Dec 2017 to Sep 2026
- Cash cash equivalents restricted cash and restricted cash equivalents including disposal group and discontinued operations42 · Dec 2017 to Sep 2026
- Stockholders equity including portion attributable to noncontrolling interest42 · Dec 2017 to Sep 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value40 · Dec 2017 to Sep 2026
- Allocated share based compensation expense40 · Dec 2017 to Sep 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect40 · Dec 2017 to Sep 2026
- Comprehensive loss40 · Dec 2017 to Sep 2026
- Depreciation and amortization40 · Dec 2017 to Sep 2026
- Effect of exchange rate on cash cash equivalents restricted cash and restricted cash equivalents including disposal group and discontinued operations40 · Dec 2017 to Sep 2026
- Fair value measurement with unobservable inputs reconciliation recurring basis liability gain loss included in earnings40 · Dec 2017 to Sep 2026
- General and administrative expense (US GAAP)40 · Dec 2017 to Sep 2026
- Increase decrease in accounts payable40 · Dec 2017 to Sep 2026
- Increase decrease in accounts receivable40 · Dec 2017 to Sep 2026
- Increase decrease in contract with customer liability40 · Dec 2017 to Sep 2026
- Increase decrease in other accounts payable and accrued liabilities40 · Dec 2017 to Sep 2026
- Increase decrease in other operating capital net40 · Dec 2017 to Sep 2026
- Increase decrease in prepaid expense40 · Dec 2017 to Sep 2026
- Interest income expense nonoperating net40 · Dec 2017 to Sep 2026
- Interest paid net40 · Dec 2017 to Sep 2026
- Net cash provided by used in financing activities40 · Dec 2017 to Sep 2026
- Net cash provided by used in investing activities40 · Dec 2017 to Sep 2026
- Net cash provided by used in operating activities40 · Dec 2017 to Sep 2026
- Non-cash interest expense40 · Dec 2017 to Sep 2026
Product8 concepts · 574 facts · Dec 2017 to Sep 2026
- Revenue549 · Dec 2017 to Sep 2026
- Operating expenses (US GAAP)9 · Mar 2023 to Mar 2024
- Related party transaction amounts of transaction9 · Mar 2023 to Dec 2024
- Contract with customer asset cumulative catch up adjustment to revenue change in estimate of transaction price3 · Mar 2026 to Sep 2026
- Accrued rebates, Additions1 · Sep 2026
- Accrued rebates, Deductions1 · Sep 2026
- Contract with customer liability revenue recognized1 · Sep 2026
- Deferred revenue, Additions1 · Sep 2026
Geography1 concept · 87 facts · Dec 2017 to Sep 2026
- Revenue87 · Dec 2017 to Sep 2026
KPI2 concepts · 5 facts · Jun 2025 to Sep 2026
- Median Overall Survival4 · Jun 2025 to Sep 2026
- Service and other revenue1 · Sep 2025
Segments
661 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service25 members · 574 facts
- Non Cash Royalty Revenue68 · Mar 2019 to Sep 2026
- Other60 · Mar 2020 to Dec 2025
- Research And Development Services54 · Dec 2017 to Dec 2023
- Non Cash Royalty Revenue Related To The Sale Of Future Royalties47 · Mar 2019 to Sep 2026
- Grant Revenue [Member]42 · Dec 2017 to Dec 2021
- Research And Development Revenue42 · Dec 2017 to Sep 2026
- License Fee Revenue34 · Mar 2019 to Dec 2023
- Revenue33 · Mar 2020 to Sep 2026
- Clinical Product Revenue32 · Sep 2021 to Dec 2025
- Recognition of deferred revenue [Member]31 · Mar 2019 to Sep 2023
- License and collaboration milestones [Member]19 · Dec 2017 to Mar 2022
- Pre Commercial Product Revenue17 · Dec 2023 to Sep 2026
- Other Revenues [Member]16 · Dec 2017 to Dec 2021
- Recognition Of Deferred Research And Development Revenue14 · Dec 2017 to Dec 2023
- Royalty sales milestone [Member]12 · Dec 2019 to Dec 2022
- Research And Development Manufacturing Services11 · Mar 2023 to Dec 2023
- Manufacturing services [Member]10 · Mar 2019 to Dec 2019
- Clinical Research Services9 · Mar 2023 to Dec 2024
- Non-cash royalty revenue [Member]8 · Dec 2018 to Dec 2022
- License and Collaboration Revenue [Member]4 · Jun 2019 to Sep 2019
- Non Cash Revenue Related To Sale Of Future Royalties3 · Dec 2023 to Dec 2025
- Clinical product revenue [Member]2 · Dec 2021
- Deferred Revenue2 · Sep 2026
- Pre Commercial Product Rebates2 · Sep 2026
- Upfront License Fee [Member]2 · Dec 2019
Statement geographical4 members · 87 facts
- US40 · Dec 2017 to Sep 2026
- Non Us36 · Dec 2018 to Dec 2025
- Rest Of World [Member]7 · Dec 2018 to Dec 2024
- Europe [Member]4 · Dec 2017 to Mar 2020
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary19 claims from 1 report · Sep 2026
- Management discussion (MD&A) commentary20 claims from 1 report · Sep 2026
Earnings calls
12 calls · Aug 2022 to Aug 2025Transcripts with management claims and analyst questions, one per fiscal period.
- FY2025 Q22025-08-27
- FY2025 Q12025-05-12
- FY2024 Q42025-03-11
- FY2024 Q32024-11-12
- FY2024 Q22024-08-08
- FY2024 Q12024-05-07
- FY2023 Q42024-03-14
- FY2023 Q32023-11-07
- FY2023 Q12023-05-09
- FY2022 Q42023-03-14
- FY2022 Q32022-11-08
- FY2022 Q22022-08-09
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Ask about this company in your AI model
Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.
Use FactIQ to get the revenue, net income and operating income of Agenus Inc. (AGEN) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 20, 2026) and refreshed every few hours.